Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Lucieli Ceolin"'
Autor:
Rafael Selbach Scheffel, Ana Patrícia de Cristo, Mirian Romitti, Carla Vaz Ferreira Vargas, Lucieli Ceolin, André B. Zanella, Jose Miguel Dora, Ana Luiza Maia
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 64, Iss 6, Pp 751-757 (2020)
ABSTRACT Objective: Although the prognostic role of BRAFV600E mutation in papillary thyroid carcinoma (PTC) is controversial, the American Thyroid Association (ATA) includes the mutational status in their risk stratification system. To evaluate the i
Externí odkaz:
https://doaj.org/article/9325fbe93306410e9b04e4a8fdb10dcb
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study
Autor:
Rui M B Maciel, Cleber P Camacho, Lígia V M Assumpção, Natassia E Bufalo, André L Carvalho, Gisah A de Carvalho, Luciana A Castroneves, Francisco M de Castro Jr, Lucieli Ceolin, Janete M Cerutti, Rossana Corbo, Tânia M B L Ferraz, Carla V Ferreira, M Inez C França, Henrique C R Galvão, Fausto Germano-Neto, Hans Graf, Alexander A L Jorge, Ilda S Kunii, Márcio W Lauria, Vera L G Leal, Susan C Lindsey, Delmar M Lourenço Jr, Léa M Z Maciel, Patrícia K R Magalhães, João R M Martins, M Cecília Martins-Costa, Gláucia M F S Mazeto, Anelise I Impellizzeri, Célia R Nogueira, Edenir I Palmero, Cencita H C N Pessoa, Bibiana Prada, Débora R Siqueira, Maria Sharmila A Sousa, Rodrigo A Toledo, Flávia O F Valente, Fernanda Vaisman, Laura S Ward, Shana S Weber, Rita V Weiss, Ji H Yang, Magnus R Dias-da-Silva, Ana O Hoff, Sergio P A Toledo, Ana L Maia
Publikováno v:
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstr
Externí odkaz:
https://doaj.org/article/37d0d78e06b24b48bb6c7725c95f14cc
Autor:
Wallace Klein Schwengber, Vitor Bock Silveira, Guilherme Moreira Hetzel, Amanda Robaina, Lucieli Ceolin, Marli Teresinha Camelier, Iuri Goemann, Roberta Rigo Dalla Corte, Rafael Selbach Scheffel, Renato Gorga Bandeira de Mello, Ana Luiza Maia, José Miguel Dora
Publikováno v:
Metabolites, Vol 12, Iss 5, p 375 (2022)
Background: Type 2 Deiodinase (DIO2) converts thyroxine (T4) into the active hormone triiodothyronine (T3). Thr92Ala DIO2 polymorphism has been associated with reduced conversion of T4 into T3 and central nervous system hypothyroidism. However, how T
Externí odkaz:
https://doaj.org/article/9578a90941f34ceab36f668881b8defe
Autor:
Lucieli Ceolin, Mirian Romitti, Débora Rodrigues Siqueira, Carla Vaz Ferreira, Jessica Oliboni Scapineli, Beatriz Assis-Brazil, Rodolfo Vieira Maximiano, Tauanne Dias Amarante, Miriam Celi de Souza Nunes, Gerald Weber, Ana Luiza Maia
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147840 (2016)
BACKGROUND:The RET S836S variant has been associated with early onset and increased risk for metastatic disease in medullary thyroid carcinoma (MTC). However, the mechanism by which this variant modulates MTC pathogenesis is still open to discuss. Of
Externí odkaz:
https://doaj.org/article/b7180974fe124a709084eeae8b936868
Autor:
Hélène Lasolle, Andrea Schiavo, Adrien Tourneur, Pierre Gillotay, Bárbara de Faria da Fonseca, Lucieli Ceolin, Olivier Monestier, Benilda Aganahi, Laura Chomette, Marina Malta Letro Kizys, Lieven Haenebalcke, Tim Pieters, Steven Goossens, Jody Haigh, Vincent Detours, Ana Luiza Silva Maia, Sabine Costagliola, Mírian Romitti
Thyroid cancer is the most common endocrine malignancy and several genetic events have been described to promote the development of thyroid carcinogenesis. Besides the effects of specific mutations on thyroid cancer development, the molecular mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73d0e9990de70b1176c1950f430c8674
https://doi.org/10.1101/2023.03.30.534915
https://doi.org/10.1101/2023.03.30.534915
Autor:
Helene Lasolle, Pierre Gillotay, Lucieli Ceolin, Benilda Aganahi, Letro Kizys Marina Malta, Maia Ana Luiza, Sabine Costagliola, Mirian Romitti
Publikováno v:
Endocrine Abstracts.
Autor:
Ana Patrícia de Cristo, José Miguel Dora, André Borsatto Zanella, Rafael Selbach Scheffel, Lucieli Ceolin, Mirian Romitti, Ana Luiza Maia, Carla Vaz Ferreira Vargas
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 64, Iss 6, Pp 751-757 (2020)
Archives of Endocrinology and Metabolism, Volume: 64, Issue: 6, Pages: 751-757, Published: 28 AUG 2020
Archives of Endocrinology and Metabolism, Issue: ahead, Published: 28 AUG 2020
Archives of Endocrinology and Metabolism, 64 (6
Archives of Endocrinology and Metabolism v.64 n.6 2020
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Archives of Endocrinology and Metabolism, Volume: 64, Issue: 6, Pages: 751-757, Published: 28 AUG 2020
Archives of Endocrinology and Metabolism, Issue: ahead, Published: 28 AUG 2020
Archives of Endocrinology and Metabolism, 64 (6
Archives of Endocrinology and Metabolism v.64 n.6 2020
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Objective: Although the prognostic role of BRAFV600E mutation in papillary thyroid carcinoma (PTC) is controversial, the American Thyroid Association (ATA) includes the mutational status in their risk stratification system. To evaluate the impact of
Autor:
Rafael Selbach, Scheffel, Ana Patrícia, de Cristo, Mirian, Romitti, Carla Vaz Ferreira, Vargas, Lucieli, Ceolin, André B, Zanella, Jose Miguel, Dora, Ana Luiza, Maia
Publikováno v:
Archives of endocrinology and metabolism. 64(6)
Although the prognostic role of BRAFPTC patients attending a university-based hospital who had the analysis of the BRAFOf the 134 patients evaluated, 44 (32.8%) carried BRAFInclusion of BRAF
Autor:
Rafael Selbach Scheffel, Lucieli Ceolin, Antônio Felippe Benini, Carla Vaz Ferreira Vargas, Ana Luiza Maia, Márcia Silveira Graudenz
Publikováno v:
Endocrine. 70(3)
Elevated serum levels of carbohydrate antigen 19.9 (CA19.9), a well-established tumor marker in pancreatic neoplasms, has been proposed as a prognostic marker of tumor aggressiveness in medullary thyroid carcinoma (MTC). A hypothesis of C-cell dediff
Autor:
Carla Vaz Ferreira, Mirian Romitti, Ana Luiza Maia, Ana Paula Palauro Goularte, Lucieli Ceolin
Publikováno v:
Experimental and Molecular Pathology. 105:110-114
Background Changes in global DNA methylation have been suggested to cause genomic instability leading to increased risk of cancer. The accumulation of epigenetic changes is believed to contribute to tumorigenesis and dedifferentiation, but the effect